Verified peer comparison
CytomX Therapeutics vs BlackRock TCP Capital Financial Comparison
Direct answer
CytomX Therapeutics and BlackRock TCP Capital are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- CytomX Therapeutics Revenue
- 76,201,000 USD
- BlackRock TCP Capital Revenue
- -76,346,573 USD
- CytomX Therapeutics Operating income
- -22,364,000 USD
- BlackRock TCP Capital Operating income
- -22,839,866 USD